Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Hemoptysis
NCT02781597Phase 3Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jan 2011
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in hemoptysis comparing Tranexamic acid with Placebo (2 arms). Primary endpoint: Change in severity of hemoptysis at 2 days. Started Jan 2011; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemoptysis
Beyond the preview
Go deeper on NCT02781597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02781597.